Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB01545IllicitInvestigationalSmall molecule
Ethyl loflazepate: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on GABA(A) Receptor and GABA(A) Receptor Benzodiazepine Binding Site
- Formula / weight
- C18H14ClFN2O3 · 360.767 g/mol (avg)
- Also known as
- Ethyl fluclozepate
Resolves to
Clinical / RWD
Structure
InChIKey
CUCHJCMWNFEYOM-UHFFFAOYSA-NSMILESCCOC(=O)C1N=C(C2=CC=CC=C2F)C2=C(NC1=O)C=CC(Cl)=C2What you can answer from here — as of September 23, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which companies are running trials of Ethyl loflazepate, in which indications and phases, and which of those programs are still active?